Lusay, Aida D.
HRN: 22-00-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFTRIAXONE 1G (VIAL)
09/29/2022
10/02/2022
IV
2g
Q 24H
S/P Debridement Of Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes